Author:
Kandagalla Shivananda,Grishina Maria,Potemkin Vladimir,Shekarappa Sharath Belenahalli,Gollapalli Pavan
Publisher
Springer International Publishing
Reference37 articles.
1. Karamouzis, M.V., Konstantinopoulos, P.A., Papavassiliou, A.G.: Roles of CREB-binding protein (CBP)/p300 in respiratory epithelium tumorigenesis. Cell Res. 17, 324–332 (2007). https://doi.org/10.1038/cr.2007.10
2. Dutto, I., Scalera, C., Prosperi, E.: CREBBP and p300 lysine acetyl transferases in the DNA damage response. Cell. Mol. Life Sci. 75(8), 1325–1338 (2017). https://doi.org/10.1007/s00018-017-2717-4
3. Mees, S.T., Mardin, W.A., Wendel, C., et al.: EP300-A miRNA-regulated metas-tasis suppressor gene in ductal adenocarcinomas of the pancreas. Int. J. Cancer 126, 114–124 (2010). https://doi.org/10.1002/ijc.24695
4. Yang, H., Pinello, C.E., Luo, J., et al.: Small-molecule inhibitors of acetyltrans-ferase p300 identified by high-throughput screening are potent anticancer agents. Mol. Cancer Ther. 12, 610–620 (2013). https://doi.org/10.1158/1535-7163.MCT-12-0930
5. Bi, Y., Zhang, L., et al.: EP300 promotes tumor development and correlates with poor prognosis in esophageal squamous carcinoma. Oncotarget 9(1), s376–s392 (2018)